Prostate Cancer Trial, Recruiting NCT05582876 Sponsor: Medical University of Bialystok Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT05582876
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Group 1 – Newly diagnosed prostate cancer (before treatment):

  • You have been diagnosed with prostate cancer confirmed by a tissue sample (biopsy)
  • Your cancer has been classified as medium or high risk based on specific scoring systems used by doctors (Gleason score, cancer stage, or PSA blood test levels)
  • Your kidney function is within an acceptable range to safely receive the contrast dye used in the scan (confirm with trial site)
  • You are 18 years of age or older
  • You have already had a detailed MRI scan of your prostate/pelvis within the last 30 days
  • You are willing to sign a consent form to take part in the study

Group 2 – Prostate cancer that has come back after treatment:

  • You previously had prostate cancer confirmed by biopsy and have already completed a main treatment (surgery or radiotherapy)
  • If you had surgery to remove the prostate: your PSA blood test has risen to a level that suggests the cancer may have returned, based on specific measurements over time (confirm exact values with trial site)
  • If you had radiotherapy: your PSA blood test has risen by 2 ng/ml above its lowest recorded level after treatment
  • You are 18 years of age or older
  • You are willing to sign a consent form to take part in the study

Who may not be able to join:

  • You have metal implants, pacemakers, stimulators, or prostheses inside your body that make an MRI scan unsafe
  • You experience claustrophobia (fear of enclosed spaces)
  • Your body size is too large to fit inside the scanning machine (confirm with trial site)
  • You have a known allergy or medical reason (such as kidney failure) that prevents you from receiving the special radioactive tracer or dye used in the scan
  • You are currently being treated for a cancer other than prostate cancer
  • You are already taking part in another clinical trial
  • You are not willing or able to sign a consent form
  • You are under 18 years of age

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 85 664 67 83

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Medical University of Bialystok
Registry
ClinicalTrials.gov
Start date
10 January 2023
Est. completion
31 January 2026

Where this trial is recruiting

🇵🇱 Poland

Primary endpoints

Sensivity of the radiopharmaceutical 68Ga-PSMA-11 compared to PET/MR and PET/CT

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov